Research
Featured research
Featured research topics
GLP-1
Oncology
Flu/RSV
Measles
Cardiovascular
Real-world aspirin avoidance after HeartMate 3 implantation
Aspirin use after HeartMate 3 implantation fell from 90.2% to 52.7% after new trial evidence, with no higher adjusted risk of death or major complications.
Syntactic and semantic normalization of 2.5 million cancer staging records
See how Truveta normalized cancer staging data from 2.5 million records extracted from clinical notes by a large language model into a research-ready format.
GLP-1 vs non-GLP-1 anti-obesity medications: Changes in depression severity
Antihypertensive prescribing patterns and blood pressure control in adults with food insecurity
Food insecurity and antihypertensive medication adherence among adults with hypertension
GLP-1 vs. non-GLP-1 anti-obesity medications: Differences in patient profiles
GLP-1 RA prescription trends: January 2019 – September 2026
GLP-1 RAs reached 8.73% of prescriptions in September 2026. Explore the latest trends in tirzepatide, semaglutide, orforglipron, and first-time prescribing.
GLP-1 prescriptions remained elevated three months after Medicare GLP-1 Bridge launch
Understanding the real-world burden of ornithine transcarbamylase deficiency (OTCD): New insights into a rare disease
AMCP Nexus: Early uptake of oral semaglutide for obesity (Wegovy pill)
CGM use associated with lower risk of death and cardiovascular events in adults with type 2 diabetes
CGM use in adults with type 2 diabetes on basal insulin was linked to 44% lower risk of death and fewer heart attacks and strokes in…
E-bike injuries increased at a rate 100 times greater than traditional bicycle injuries through summer 2026
ED visits associated with e-bikes increased across every age group, but the increase was most pronounced among children and adolescents under 18 years, whose rate rose…

